225 related articles for article (PubMed ID: 24326901)
1. Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation.
Noteboom B; Jenkins S; Maiorana A; Cecins N; Ng C; Hill K
J Cardiopulm Rehabil Prev; 2014; 34(1):75-9. PubMed ID: 24326901
[TBL] [Abstract][Full Text] [Related]
2. Frequency of referral to and attendance at a pulmonary rehabilitation programme amongst patients admitted to a tertiary hospital with chronic obstructive pulmonary disease.
Johnston K; Young M; Grimmer K; Antic R; Frith P
Respirology; 2013 Oct; 18(7):1089-94. PubMed ID: 23711304
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity associated with referral to pulmonary rehabilitation in people hospitalized with chronic obstructive pulmonary disease.
Li LS; Caughey G; Johnston K
J Cardiopulm Rehabil Prev; 2014; 34(6):430-6. PubMed ID: 25166258
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study.
Gill JM; Klinkman MS; Chen YX
J Am Board Fam Med; 2010; 23(4):499-508. PubMed ID: 20616292
[TBL] [Abstract][Full Text] [Related]
5. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.
Crisafulli E; Costi S; Luppi F; Cirelli G; Cilione C; Coletti O; Fabbri LM; Clini EM
Thorax; 2008 Jun; 63(6):487-92. PubMed ID: 18203818
[TBL] [Abstract][Full Text] [Related]
6. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
[TBL] [Abstract][Full Text] [Related]
7. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM
Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230
[TBL] [Abstract][Full Text] [Related]
8. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
[TBL] [Abstract][Full Text] [Related]
9. Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patients.
Solem CT; Lee TA; Joo MJ; Lambert BL; Walton SM; Pickard AS
Am J Geriatr Pharmacother; 2012 Apr; 10(2):110-122.e1. PubMed ID: 22280978
[TBL] [Abstract][Full Text] [Related]
10. Uptake of pulmonary rehabilitation in New Zealand by people with chronic obstructive pulmonary disease in 2009.
Levack WM; Weatherall M; Reeve JC; Mans C; Mauro A
N Z Med J; 2012 Jan; 125(1348):23-33. PubMed ID: 22282274
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of comorbidities in COPD patients by disease severity in a German population.
Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
[TBL] [Abstract][Full Text] [Related]
12. Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease.
Carreiro A; Santos J; Rodrigues F
Rev Port Pneumol; 2013; 19(3):106-13. PubMed ID: 23664247
[TBL] [Abstract][Full Text] [Related]
13. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
[TBL] [Abstract][Full Text] [Related]
14. The impact of chronic obstructive pulmonary disease exacerbation on pulmonary rehabilitation participation and functional outcomes.
Steele BG; Belza B; Cain K; Coppersmith J; Howard J; Lakshminarayan S; Haselkorn J
J Cardiopulm Rehabil Prev; 2010; 30(1):53-60. PubMed ID: 20068424
[TBL] [Abstract][Full Text] [Related]
15. Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study.
Roberts MH; Mapel DW; Hartry A; Von Worley A; Thomson H
Ann Am Thorac Soc; 2013 Aug; 10(4):290-8. PubMed ID: 23952846
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities of chronic obstructive pulmonary disease.
Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
[TBL] [Abstract][Full Text] [Related]
18. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
[TBL] [Abstract][Full Text] [Related]
19. Burden of chronic obstructive pulmonary disease in the elderly population.
Kobayashi S; Yanai M; Hanagama M; Yamanda S
Respir Investig; 2014 Sep; 52(5):296-301. PubMed ID: 25169845
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
Ágh T; Inotai A; Mészáros Á
Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
